DOCSLIB.ORG

Downregulation of NSD3 (WHSC1L1) Inhibits Cell Proliferation and Migration Via ERK1/2 Deactivation and Decreasing CAPG Expression in Colorectal Cancer Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Downregulation of NSD3 (WHSC1L1) Inhibits Cell Proliferation and Migration Via ERK1/2 Deactivation and Decreasing CAPG Expression in Colorectal Cancer Cells OncoTargets and Therapy Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH Downregulation of NSD3 (WHSC1L1) inhibits cell proliferation and migration via ERK1/2 deactivation and decreasing CAPG expression in colorectal cancer cells This article was published in the following Dove Press journal: OncoTargets and Therapy Lanjuan Yi1 Purpose: NSD3 (WHSC1L1) is a protein lysine methyltransferase that is recurrently Lanjie Yi2 amplified (8p11.23) in several cancer types, and its upregulation is involved in tumor cell Qing Liu3 proliferation, metastasis, and epithelial-mesenchymal transition (EMT). We aimed to evalu- Chen Li4 ate its potential function as an oncogenic force in colorectal cancer (CRC), and to elucidate relevant mechanisms of its oncogenic activity. 1Department of gastroenterology, Yantai Shan Hospital, Yantai, Shandong 264001, Materials and methods: NSD3 levels were analyzed in human CRC and adjacent normal People’s Republic of China; 2Research tissues or cells by Western blot analysis and RT-qPCR. Expression levels of the proteins were Office of Clinical literature, Nanjing detected by Western blot analysis and RT-qPCR. University of Chinese Medicine, Nanjing, fi Jiangsu 210023, People’s Republic of Results: NSD3 was signi cantly upregulated in both CRC tissues and cell lines. China; 3Department of Nosocomial Knockdown of NSD3 expression resulted in significant decreases in CRC cell proliferation, Infection Control, Xuzhou Hospital of migration, and EMT process marker proteins vimentin, simultaneously reducing E-cadherin Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, and N-cadherin expression. The opposite results were observed when NSD3 was over- Xuzhou, Jiangsu 310015, People’s expressed. Additionally, overexpressing of NSD3 dramatically activated the extracellular Republic of China; 4Department of signal-regulated kinase 1/2 (ERK1/2) signaling pathway and enhanced actin-capping protein Gastroenterology, Xuzhou Chinese Medicine Hospital Affiliated to Nanjing (CAPG) expression. Furthermore, the proliferation and migration abilities evidently facili- University of Chinese Medicine, Xuzhou, tated by pcDNA3.1(+) expression vector containing full-length CDS of NSD3 (pcDNA3.1 Jiangsu 310015, People’s Republic of China (+)-NSD3, or NSD3) were partially decreased after incubation with ERK1/2 signaling path- way inhibitor (PD98059) and/or specific siRNA against CAPG (siCAPG) in SW480 and HT- 29 CRC cells. Conclusion: NSD3 overexpression stimulated CRC cell proliferation and migration through targeting the ERK1/2 signaling pathway and downstream CAPG. Thus, NSD3 could serve as a promising target for anticancer drug development for patients with CRC. Keywords: colorectal cancer, histone methyltransferase NSD3, extracellular signal- regulated kinase 1/2, actin-capping protein (CAPG) Plain Language Summary Correspondence: Chen Li The purpose of the experiment is to evaluate potential function of NSD3 Department of Gastroenterology, Xuzhou Chinese Medicine Hospital (WHSC1L1), aprotein lysine methyltransferase, as an oncogenic force in colorectal Affiliated to Nanjing University of Chinese cancer (CRC), and to elucidate relevant mechanisms of its oncogenic activity. Our Medicine, No.169, Zhongshan South Road, Xuzhou, Jiangsu 221000, People’s invitro studies revealed that the expression of NSD3 was obviously higher in CRC Republic of China tissues than in normal tissues. Knockdown of NSD3 expression resulted in sig- Tel+ 86 0516 6869 2031 Email [email protected] nificant decreases in CRC cell proliferation, migration, and epithelial-mesenchymal submit your manuscript | www.dovepress.com OncoTargets and Therapy 2019:12 3933–3943 3933 DovePress © 2019 Yi et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work http://doi.org/10.2147/OTT.S191732 you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Yi et al Dovepress transition (EMT) process marker proteins vimentin, simul- we examined its effect on the regulation of extracellular taneously reducing E-cadherin and N-cadherin expression. signal regulated kinases 1 and 2 (ERK1/2) signaling path- The opposite results were observed when NSD3 was over- way and actin-capping protein (CAPG), which are strongly expressed. NSD3 overexpression in CRC cells facilitated associated with tumor cell proliferation, apoptosis, metas- cell proliferation and migration, and promoted cell EMT tasis, and EMT.15–18 progress via increasing CAPG expression and ERK1/2 signaling pathway activation. Additionally, we also Materials and methods demonstrated that ERK1/2 signaling pathway could facil- Human CRC tissues and cell lines itate CAPG-induced proliferation and migration in CRC In total, CRC tissues (n =24) and adjacent normal tissues cells. These results imply NSD3 may become a reliable (n =26) were collected after surgical resection at the CRC biomarker for diagnoses and atarget for precise Xuzhou Hospital of Traditional Chinese Medicine therapy. Affiliated to Nanjing University of Chinese Medicine Introduction (Xuzhou, Jiangsu, China).All samples were immediately snap-frozen in liquid nitrogen and stored at −80 °C until Colorectal cancer (CRC) is a type of gastrointestinal neo- total RNA was extracted. The researches were approved by plasm with the highest rates both in incidence and the Independent Ethics Committee (IEC) of Xuzhou mortality.1 More than 49 million patients worldwide die Hospital of Traditional Chinese Medicine Affiliated to of CRC each year.2,3 In China, the morbidity of CRC has Nanjing University of Chinese Medicine, and all patients been increasing since 2000.4 As most CRC cases are provided written informed consent. The study methodolo- diagnosed at metastatic stages, the prognosis of CRC gies conformed to the standards set by the Declaration of patients is poor.5 Therefore, it is urgent to develop early Helsinki. diagnose and effective intervene preventing tumors from The human normal colorectal mucosa cell line (FHC) metastasize in CRC. and seven human CRC cell lines, including Lovo, SW480, It has been widely identified that aberrant expression of SW620, HT-29, HCT-116, Caco-2, and SW48, were all histone methylation and its regulator histone methyltrans- purchased from the Cell Bank of the Chinese Academy of ferase are closely related to various cancers.6 NSD3, also Sciences (Shanghai, China). Cells were cultured in high- known as Wolf - Hirschhorn syndrome candidate 1-like 1 glucose Dulbecco’s modified Eagle’s medium (Invitrogen, (WHSC1L1), is a nuclear protein mapped at chromosome Carlsbad, CA, USA) with 10% fetal bovine serum 8p11.23 and functions as a chromatin regulator by mod- (Hyclone Laboratories, Inc., South Logan, UT, USA) and ulating the expression of genes through demethylation of 100 μg/mL streptomycin sulfate (Gibco, Rockville, MD, lysine 36 on histone H3 (H3K36me2).7 NSD3 plays USA) in plastic tissue culture plates. All cells were main- a critical role in the expansion of various tumors.8 It can tained at 37 °C in a humidified atmosphere containing 5% interact with NUP98,9 NUT,10 E2F2,11 BRD4, or CHD8,12 CO . resulting in occurrence of tumors or proliferation and 2 invasion of cancer cells in leukemogenesis, NUT midline carcinoma (NMC), and breast cancer. Collectively, NSD3 RNA extraction and quantitative real-time plays an important role in human carcinogenesis, and it reverse transcription PCR (RT-qPCR) may serve as a potential druggable target for selective Total RNA was extracted using TRIzol Reagent (Invitrogen, CRC therapy in the future. However, the functional Carlsbad, CA, USA), and cDNA was synthesized from 2 μg mechanisms of NSD3 in CRC have not been clarified yet. of RNA using the PrimeScriptTM RT Reagent Kit (Takara Current findings show that epithelial-mesenchymal Biotechnology, Dalian, China) according to the manufac- transition (EMT) is an important mechanism for the metas- turer’s instructions. The sequences for sense (S) and tasis of malignant tumors.13 By EMT epithelial-derived antisense (AS) primers are as follows: human-NSD3-S, malignant cells acquire the phenotype of mesenchymal 5′-AAG AGC CAC CGC CTG TTA AA-3′, human-NSD3- cell and the ability of invasion and metastasis.14 Herein, AS, 5′- GCT GTC ACA AAT GGA GGT GC-3′; human- we investigated the effects of NSD3 on CRC cell prolif- E-cadherin-S, 5′-CGG GAA TGC AGT TGA GGA TC-3′, eration, metastasis and EMT progress, and then explored human-E-cadherin-AS, 5′-AGG ATG GTG TAA GCG ATG the molecular mechanism of NSD3 in CRC. Specifically, GC-3′; human-N-cadherin-S, 5′-AAG AGG CCG AGA 3934 submit your manuscript | www.dovepress.com OncoTargets and Therapy 2019:12 DovePress Dovepress Yi et al CTT GTG AA-3′, human-N-cadherin-AS, 5′-CAC TGG plate at l×106/well, and siRNA were transfected with GGA TAA GGG AAG GT-3′; human-vimentin-S, 5′-GAG Lipofectamine2000 (Invitrogen, Carlsbad, CA, USA) AAC TTT GCC GTT GAA GC-3′, human-vimentin-AS, 5′- when the cell abundance was up to 70%~80%. The final GCT TCC TGT AGG TGG CAA TC-3′;human-CAPG-S, concentration of siRNA transfection was 200 nm/L. After 5′-GGG GAC TCC TAC CTA GTG CTG-3′, human-CAPG transfection for 48 h, the knockdown efficiency was eval- -AS, 5′-CAC CAC CTT CCT GGT ACT TGA-3′.RT- uated by Western blot analysis. qPCR was conducted using SYBR Premix Ex Taq™ (Takara, Dalian, China) at 95 °C for 30 sec, followed by Construction and transfection of 40 cycles of 95 °C for 5 sec and 60 °C for 34 sec in the ABI overexpression vectors NSD3 StepOnePlus Real-time PCR system. The relative fold A pair of primers for the known NSD3 coding sequences was changes in mRNA expression were calculated using the designed as mentioned earlier.
Load more

Recommended publications
  • FGFR1 Fusion and Amplification in a Solid Variant of Alveolar Rhabdomyosarcoma
    Modern Pathology (2011) 24, 1327–1335 & 2011 USCAP, Inc. All rights reserved 0893-3952/11 $32.00 1327 FOXO1–FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma Jinglan Liu1,2, Miguel A Guzman1,2, Donna Pezanowski1, Dilipkumar Patel1, John Hauptman1, Matthew Keisling3, Steve J Hou2,3, Peter R Papenhausen4, Judy M Pascasio1,2, Hope H Punnett1,5, Gregory E Halligan2,6 and Jean-Pierre de Chadare´vian1,2 1Department of Pathology and Laboratory Medicine, St Christopher’s Hospital for Children, Philadelphia, PA, USA; 2Drexel University College of Medicine, Philadelphia, PA, USA; 3Department of Pathology and Laboratory Medicine, Hahnneman University Hospital, Philadelphia, PA, USA; 4Laboratory Corporation of America, The Research Triangle Park, NC, USA; 5Department of Pathology and Laboratory Medicine, Temple University School of Medicine, Philadelphia, PA, USA and 6Department of Pediatrics, Section of Oncology, St Christopher’s Hospital for Children, Philadelphia, PA, USA Rhabdomyosarcoma is the most common pediatric soft tissue malignancy. Two major subtypes, alveolar rhabdomyosarcoma and embryonal rhabdomyosarcoma, constitute 20 and 60% of all cases, respectively. Approximately 80% of alveolar rhabdomyosarcoma carry two signature chromosomal translocations, t(2;13)(q35;q14) resulting in PAX3–FOXO1 fusion, and t(1;13)(p36;q14) resulting in PAX7–FOXO1 fusion. Whether the remaining cases are truly negative for gene fusion has been questioned. We are reporting the case of a 9-month-old girl with a metastatic neck mass diagnosed histologically as solid variant alveolar rhabdomyosarcoma. Chromosome analysis showed a t(8;13;9)(p11.2;q14;9q32) three-way translocation as the sole clonal aberration. Fluorescent in situ hybridization (FISH) demonstrated a rearrangement at the FOXO1 locus and an amplification of its centromeric region.
    [Show full text]
  • Text-Based Analysis of Genes, Proteins, Aging, and Cancer
    Mechanisms of Ageing and Development 126 (2005) 193–208 www.elsevier.com/locate/mechagedev Text-based analysis of genes, proteins, aging, and cancer Jeremy R. Semeiks, L.R. Grate, I.S. Mianà Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA Available online 26 October 2004 Abstract The diverse nature of cancer- and aging-related genes presents a challenge for large-scale studies based on molecular sequence and profiling data. An underexplored source of data for modeling and analysis is the textual descriptions and annotations present in curated gene- centered biomedical corpora. Here, 450 genes designated by surveys of the scientific literature as being associated with cancer and aging were analyzed using two complementary approaches. The first, ensemble attribute profile clustering, is a recently formulated, text-based, semi- automated data interpretation strategy that exploits ideas from statistical information retrieval to discover and characterize groups of genes with common structural and functional properties. Groups of genes with shared and unique Gene Ontology terms and protein domains were defined and examined. Human homologs of a group of known Drosphila aging-related genes are candidates for genes that may influence lifespan (hep/MAPK2K7, bsk/MAPK8, puc/LOC285193). These JNK pathway-associated proteins may specify a molecular hub that coordinates and integrates multiple intra- and extracellular processes via space- and time-dependent interactions with proteins in other pathways. The second approach, a qualitative examination of the chromosomal locations of 311 human cancer- and aging-related genes, provides anecdotal evidence for a ‘‘phenotype position effect’’: genes that are proximal in the linear genome often encode proteins involved in the same phenomenon.
    [Show full text]
  • Ectopic Protein Interactions Within BRD4–Chromatin Complexes Drive Oncogenic Megadomain Formation in NUT Midline Carcinoma
    Ectopic protein interactions within BRD4–chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma Artyom A. Alekseyenkoa,b,1, Erica M. Walshc,1, Barry M. Zeea,b, Tibor Pakozdid, Peter Hsic, Madeleine E. Lemieuxe, Paola Dal Cinc, Tan A. Incef,g,h,i, Peter V. Kharchenkod,j, Mitzi I. Kurodaa,b,2, and Christopher A. Frenchc,2 aDivision of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; bDepartment of Genetics, Harvard Medical School, Boston, MA 02115; cDepartment of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; dDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA 02115; eBioinfo, Plantagenet, ON, Canada K0B 1L0; fDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136; gBraman Family Breast Cancer Institute, University of Miami Miller School of Medicine, Miami, FL 33136; hInterdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136; iSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL 33136; and jHarvard Stem Cell Institute, Cambridge, MA 02138 Contributed by Mitzi I. Kuroda, April 6, 2017 (sent for review February 7, 2017; reviewed by Sharon Y. R. Dent and Jerry L. Workman) To investigate the mechanism that drives dramatic mistargeting of and, in the case of MYC, leads to differentiation in culture (2, 3). active chromatin in NUT midline carcinoma (NMC), we have Similarly, small-molecule BET inhibitors such as JQ1, which identified protein interactions unique to the BRD4–NUT fusion disengage BRD4–NUT from chromatin, diminish megadomain- oncoprotein compared with wild-type BRD4.
    [Show full text]
  • Sleeping Beauty Mutagenesis Reveals Cooperating Mutations and Pathways in Pancreatic Adenocarcinoma
    Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma Karen M. Manna,1, Jerrold M. Warda, Christopher Chin Kuan Yewa, Anne Kovochichb, David W. Dawsonb, Michael A. Blackc, Benjamin T. Brettd, Todd E. Sheetzd,e,f, Adam J. Dupuyg, Australian Pancreatic Cancer Genome Initiativeh,2, David K. Changi,j,k, Andrew V. Biankini,j,k, Nicola Waddelll, Karin S. Kassahnl, Sean M. Grimmondl, Alistair G. Rustm, David J. Adamsm, Nancy A. Jenkinsa,1, and Neal G. Copelanda,1,3 aDivision of Genetics and Genomics, Institute of Molecular and Cell Biology, Singapore 138673; bDepartment of Pathology and Laboratory Medicine and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles, CA 90095; cDepartment of Biochemistry, University of Otago, Dunedin, 9016, New Zealand; dCenter for Bioinformatics and Computational Biology, University of Iowa, Iowa City, IA 52242; eDepartment of Biomedical Engineering, University of Iowa, Iowa City, IA 52242; fDepartment of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, IA 52242; gDepartment of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242; hAustralian Pancreatic Cancer Genome Initiative; iCancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales 2010, Australia; jDepartment of Surgery, Bankstown Hospital, Bankstown, Sydney, New South Wales 2200, Australia; kSouth Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Liverpool, New South Wales 2170, Australia; lQueensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia; and mExperimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, United Kingdom This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2009.
    [Show full text]
  • WAPL Maintains Dynamic Cohesin to Preserve Lineage Specific Distal Gene Regulation
    bioRxiv preprint doi: https://doi.org/10.1101/731141; this version posted August 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. WAPL maintains dynamic cohesin to preserve lineage specific distal gene regulation Ning Qing Liu1, Michela Maresca1, Teun van den Brand1, Luca Braccioli1, Marijne M.G.A. Schijns1, Hans Teunissen1, Benoit G. Bruneau2,3,4, Elphѐge P. Nora2,3, Elzo de Wit1,* Affiliations 1 Division Gene Regulation, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands; 2 Gladstone Institutes, San Francisco, USA; 3 Cardiovascular Research Institute, University of California, San Francisco; 4 Department of Pediatrics, University of California, San Francisco. *corresponding author: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/731141; this version posted August 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. HIGHLIGHTS 1. The cohesin release factor WAPL is crucial for maintaining a pluripotency-specific phenotype. 2. Dynamic cohesin is enriched at lineage specific loci and overlaps with binding sites of pluripotency transcription factors. 3. Expression of lineage specific genes is maintained by dynamic cohesin binding through the formation of promoter-enhancer associated self-interaction domains. 4. CTCF-independent cohesin binding to chromatin is controlled by the pioneer factor OCT4. bioRxiv preprint doi: https://doi.org/10.1101/731141; this version posted August 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
    [Show full text]
  • Implications for the 8P12-11 Genomic Locus in Breast Cancer Diagnostics and Therapy: Eukaryotic Initiation Factor 4E-Binding Protein, EIF4EBP1, As an Oncogene
    Medical University of South Carolina MEDICA MUSC Theses and Dissertations 2018 Implications for the 8p12-11 Genomic Locus in Breast Cancer Diagnostics and Therapy: Eukaryotic Initiation Factor 4E-Binding Protein, EIF4EBP1, as an Oncogene Alexandria Colett Rutkovsky Medical University of South Carolina Follow this and additional works at: https://medica-musc.researchcommons.org/theses Recommended Citation Rutkovsky, Alexandria Colett, "Implications for the 8p12-11 Genomic Locus in Breast Cancer Diagnostics and Therapy: Eukaryotic Initiation Factor 4E-Binding Protein, EIF4EBP1, as an Oncogene" (2018). MUSC Theses and Dissertations. 295. https://medica-musc.researchcommons.org/theses/295 This Dissertation is brought to you for free and open access by MEDICA. It has been accepted for inclusion in MUSC Theses and Dissertations by an authorized administrator of MEDICA. For more information, please contact [email protected]. Implications for the 8p12-11 Genomic Locus in Breast Cancer Diagnostics and Therapy: Eukaryotic Initiation Factor 4E-Binding Protein, EIF4EBP1, as an Oncogene by Alexandria Colett Rutkovsky A dissertation submitted to the faculty of the Medical University of South Carolina in fulfillment of the requirements for the degree of Doctor of Philosophy in the College of Graduate Studies Biomedical Sciences Department of Pathology and Laboratory Medicine 2018 Approved by: Chairman, Advisory Committee Stephen P. Ethier Co-Chairman Robin C. Muise-Helmericks Amanda C. LaRue Victoria J. Findlay Elizabeth S. Yeh Copyright by Alexandria Colett Rutkovsky 2018 All Rights Reserved This work is dedicated to the fight against cancer. ACKNOWLEDGEMENTS I would like to acknowledge the Hollings Cancer Center and many departments at the Medical University of South Carolina for investing the resources and training required to complete the research presented.
    [Show full text]
  • High WHSC1L1 Expression Reduces Survival Rates in Operated Breast Cancer Patients with Decreased CD8+ T Cells: Machine Learning Approach
    Journal of Personalized Medicine Article High WHSC1L1 Expression Reduces Survival Rates in Operated Breast Cancer Patients with Decreased CD8+ T Cells: Machine Learning Approach Hyung-Suk Kim 1 , Kyueng-Whan Min 2,* , Dong-Hoon Kim 3,* , Byoung-Kwan Son 4 , Mi-Jung Kwon 5 and Sang-Mo Hong 6 1 Division of Breast Surgery, Department of Surgery, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri 15588, Korea; [email protected] 2 Department of Pathology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri 15588, Korea 3 Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunanro, Seoul 03181, Korea 4 Uijeongbu Eulji Medical Center, Department of Internal Medicine, Eulji University School of Medicine, Daejeon 34824, Korea; [email protected] 5 Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 24252, Korea; [email protected] 6 Division of Endocrinology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri 15588, Korea; [email protected] * Correspondence: [email protected] (K.-W.M.); [email protected] (D.-H.K.); Tel.: +82-31-560-2346 (K.-W.M.); +82-2-2001-2392 (D.-H.K.); Fax: +82-2-31-560-2402 (K.-W.M.); +82-2-2001-2398 (D.-H.K.) Citation: Kim, H.-S.; Min, K.-W.; Kim, D.-H.; Son, B.-K.; Kwon, M.-J.; Abstract: Nuclear receptor-binding SET domain protein (NSD), a histone methyltransferase, is Hong, S.-M. High WHSC1L1 known to play an important role in cancer pathogenesis. The WHSC1L1 (Wolf-Hirschhorn syndrome Expression Reduces Survival Rates in candidate 1-like 1) gene, encoding NSD3, is highly expressed in breast cancer, but its role in the Operated Breast Cancer Patients with development of breast cancer is still unknown.
    [Show full text]
  • In SUM-44 Breast Cancer Cells and Is Associated with Era Over-Expression in Breast Cancer
    MOLECULAR ONCOLOGY 10 (2016) 850e865 available at www.sciencedirect.com ScienceDirect www.elsevier.com/locate/molonc Amplification of WHSC1L1 regulates expression and estrogen- independent activation of ERa in SUM-44 breast cancer cells and is associated with ERa over-expression in breast cancer Jonathan C. Irisha,b,1, Jamie N. Millsa,1, Brittany Turner-Iveya, Robert C. Wilsona, Stephen T. Guesta, Alexandria Rutkovskya, Alan Dombkowskib, Christiana S. Kapplera, Gary Hardimanc, Stephen P. Ethiera,* aDepartment of Pathology and Laboratory Medicine, Hollings Cancer Center, 86 Jonathan Lucas St, Charleston, SC 29425, USA bDepartment of Cancer Biology, Wayne State University School of Medicine, 540 E Canfield St, Detroit, MI 48201, USA cDepartment of Medicine and Public Health, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC 29425, USA ARTICLE INFO ABSTRACT Article history: The 8p11-p12 amplicon occurs in approximately 15% of breast cancers in aggressive Received 30 November 2015 luminal B-type tumors. Previously, we identified WHSC1L1 as a driving oncogene from Received in revised form this region. Here, we demonstrate that over-expression of WHSC1L1 is linked to over- 17 February 2016 expression of ERa in SUM-44 breast cancer cells and in primary human breast cancers. Accepted 18 February 2016 Knock-down of WHSC1L1, particularly WHSC1L1-short, had a dramatic effect on ESR1 Available online 27 February 2016 mRNA and ERa protein levels. SUM-44 cells do not require exogenous estrogen for growth in vitro; however, they are dependent on ERa expression, as ESR1 knock-down or exposure Keywords: to the selective estrogen receptor degrader fulvestrant resulted in growth inhibition.
    [Show full text]
  • Structure, Activity and Function of the NSD3 Proteinlysine
    life Review Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase Philipp Rathert Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, 70569 Stuttgart, Germany; [email protected]; Tel.: +49-711-685-64388 Abstract: NSD3 is one of six H3K36-specific lysine methyltransferases in metazoans, and the methy- lation of H3K36 is associated with active transcription. NSD3 is a member of the nuclear receptor- binding SET domain (NSD) family of histone methyltransferases together with NSD1 and NSD2, which generate mono- and dimethylated lysine on histone H3. NSD3 is mutated and hyperactive in some human cancers, but the biochemical mechanisms underlying such dysregulation are barely understood. In this review, the current knowledge of NSD3 is systematically reviewed. Finally, the molecular and functional characteristics of NSD3 in different tumor types according to the current research are summarized. Keywords: NSD3; WHSC1L1; structure and function 1. Introduction In eukaryotes, DNA is assembled into a higher order nucleoprotein structure called chromatin. Besides the condensation of the DNA, chromatin poses a variety of different functions centered around the regulation of transcription, replication, DNA repair and Citation: Rathert, P. Structure, recombination. The main unit of chromatin is the nucleosome consisting of 147 base pairs Activity and Function of the NSD3 (bp) of DNA, which is wrapped around the histone octamer comprising two molecules of Protein Lysine Methyltransferase. each core histone: H2A, H2B, H3 and H4 [1]. The linker histone protein H1 is involved in Life 2021, 11, 726. https://doi.org/ packaging nucleosomes and proteins such as condensin, cohesin, CCCTC-binding factor 10.3390/life11080726 (CTCF) or Yin Yang 1 (YY1) to organize the chromatin into higher order structures such as gene loops, topologically associated domains (TADs), chromosome territories, and chro- Academic Editor: Jean Cavarelli mosomes [2–4].
    [Show full text]
  • SLAMF7 and IL-6R Define Distinct Cytotoxic Versus Helper Memory CD8+ T Cells
    ARTICLE https://doi.org/10.1038/s41467-020-19002-6 OPEN SLAMF7 and IL-6R define distinct cytotoxic versus helper memory CD8+ T cells Lucie Loyal1,2, Sarah Warth2,3, Karsten Jürchott2,4,5, Felix Mölder 6, Christos Nikolaou 2,7, Nina Babel8, Mikalai Nienen5, Sibel Durlanik2, Regina Stark 9, Beate Kruse1,2, Marco Frentsch2, Robert Sabat7, ✉ Kerstin Wolk 7 & Andreas Thiel 1,2 The prevailing ‘division of labor’ concept in cellular immunity is that CD8+ T cells primarily 1234567890():,; utilize cytotoxic functions to kill target cells, while CD4+ T cells exert helper/inducer func- tions. Multiple subsets of CD4+ memory T cells have been characterized by distinct che- mokine receptor expression. Here, we demonstrate that analogous CD8+ memory T-cell subsets exist, characterized by identical chemokine receptor expression signatures and controlled by similar generic programs. Among them, Tc2, Tc17 and Tc22 cells, in contrast to Tc1 and Tc17 + 1 cells, express IL-6R but not SLAMF7, completely lack cytotoxicity and instead display helper functions including CD40L expression. CD8+ helper T cells exhibit a unique TCR repertoire, express genes related to skin resident memory T cells (TRM) and are altered in the inflammatory skin disease psoriasis. Our findings reveal that the conventional view of CD4+ and CD8+ T cell capabilities and functions in human health and disease needs to be revised. 1 Si-M/“Der Simulierte Mensch” a science framework of Technische Universität Berlin and Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany. 2 Regenerative Immunology and Aging, BIH Center for Regenerative Therapies, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany. 3 BCRT Flow Cytometry Lab, Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
    [Show full text]
  • Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2019 Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains Lambert, Jean-Philippe ; Picaud, Sarah ; Fujisawa, Takao ; Hou, Huayun ; Savitsky, Pavel ; Uusküla-Reimand, Liis ; Gupta, Gagan D ; Abdouni, Hala ; Lin, Zhen-Yuan ; Tucholska, Monika ; Knight, James D R ; Gonzalez-Badillo, Beatriz ; St-Denis, Nicole ; Newman, Joseph A ; Stucki, Manuel ; Pelletier, Laurence ; Bandeira, Nuno ; Wilson, Michael D ; Filippakopoulos, Panagis ; Gingras, Anne-Claude Abstract: Targeting bromodomains (BRDs) of the bromo-and-extra-terminal (BET) family offers oppor- tunities for therapeutic intervention in cancer and other diseases. Here, we profile the interactomes of BRD2, BRD3, BRD4, and BRDT following treatment with the pan-BET BRD inhibitor JQ1, revealing broad rewiring of the interaction landscape, with three distinct classes of behavior for the 603 unique interactors identified. A group of proteins associate in a JQ1-sensitive manner with BET BRDs through canonical and new binding modes, while two classes of extra-terminal (ET)-domain binding motifs medi- ate acetylation-independent interactions. Last, we identify an unexpected increase in several interactions following JQ1 treatment that define negative functions for BRD3 in the regulation of rRNA synthesis and potentially RNAPII-dependent gene expression that result in decreased cell proliferation. Together, our data highlight the contributions of BET
    [Show full text]
  • Whole-Genome Sequencing Reveals Genomic Signatures Associated with the Inflammatory Microenvironments in Chinese NSCLC Patients
    ARTICLE DOI: 10.1038/s41467-018-04492-2 OPEN Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients Cheng Wang1,2,3, Rong Yin4, Juncheng Dai1,2, Yayun Gu1,2, Shaohua Cui5, Hongxia Ma1,2, Zhihong Zhang6, Jiaqi Huang7, Na Qin1,2, Tao Jiang1,2, Liguo Geng1,2, Meng Zhu1,2, Zhening Pu1,2, Fangzhi Du1,2, Yuzhuo Wang1,2, Jianshui Yang1,2, Liang Chen8, Qianghu Wang3, Yue Jiang1,2, Lili Dong5, Yihong Yao7, Guangfu Jin 1,2, Zhibin Hu1,2, Liyan Jiang5, Lin Xu4 & Hongbing Shen1,2 1234567890():,; Chinese lung cancer patients have distinct epidemiologic and genomic features, highlighting the presence of specific etiologic mechanisms other than smoking. Here, we present a comprehensive genomic landscape of 149 non-small cell lung cancer (NSCLC) cases and identify 15 potential driver genes. We reveal that Chinese patients are specially characterized by not only highly clustered EGFR mutations but a mutational signature (MS3, 33.7%), that is associated with inflammatory tumor-infiltrating B lymphocytes (P = 0.001). The EGFR mutation rate is significantly increased with the proportion of the MS3 signature (P = 9.37 × 10−5). TCGA data confirm that the infiltrating B lymphocyte abundance is significantly higher in the EGFR-mutated patients (P = 0.007). Additionally, MS3-high patients carry a higher contribution of distant chromosomal rearrangements >1 Mb (P = 1.35 × 10−7), some of which result in fusions involving genes with important functions (i.e., ALK and RET). Thus, inflammatory infiltration may contribute to the accumulation of EGFR mutations, especially in never-smokers.
    [Show full text]